FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC ...Middle East

Medscape - News
The US Food and Drug Administration has granted accelerated approval for tepotinib for the treatment of adults with metastatic non–small cell lung cancer harboring MET exon 14 skipping alterations. FDA Approvals

Hence then, the article about fda grants met inhibitor tepotinib accelerated approval for nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC )

Apple Storegoogle play

Last updated :

Also on site :